Phase II Trial of capsaicin gel application for prevent oxaliplatin-induced peripheral neuropathy
收藏NIAID Data Ecosystem2026-03-08 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/2565376
下载链接
链接失效反馈官方服务：
资源简介：
Interventions: 0.025% w/w Capsaicin gel;Experimental Drug;Capsaicin gel
Primary outcome(s): Grade D or more peripheral neuropathy - free rate (From Grade A to E) 4 weeks after last dose of chemotherapy Patient Neurotoxicity Questionnaire (Thai version)
Study Design: Non-randomized
创建时间：
2015-07-15
